PASCAGOULA, Miss., Nov. 21, 2025 (GLOBE NEWSWIRE) -- HII’s (NYSE: HII) Ingalls Shipbuilding division successfully completed the final round of sea trials for Arleigh Burke-class guided missile destroyer Ted Stevens (DDG 128). The Ingalls Test and Trials team spent several days in port and at sea conducting a comprehensive series of acceptance test and evaluations, overseen by the Navy’s Board of Inspection and Survey (INSURV). These trials confirmed that the ship successfully demonstrated required mission c ...

Core Viewpoint - Panoro Minerals Ltd. has successfully closed the first tranche of its private placement, raising gross proceeds of C$2,918,200 through the sale of 7,295,500 units at a price of C$0.40 per unit, with plans to utilize the funds for various project developments and working capital [1][3]. Group 1: Offering Details - The first tranche of the offering consists of 7,295,500 units sold at C$0.40 each, totaling C$2,918,200 in gross proceeds [1]. - Each unit includes one common share and one common share purchase warrant, allowing the purchase of an additional common share at C$0.60 until November 21, 2028 [2]. - The offering is being managed by Red Cloud Securities Inc. as the lead agent and Cormark Securities Inc. as co-agent [1]. Group 2: Use of Proceeds - The net proceeds from the offering will be allocated for infill drilling, metallurgical testing, pre-feasibility engineering, and an updated preliminary economic assessment for the Cotabambas Copper-Gold-Silver project [3]. - Additional funds will be directed towards working capital and general corporate purposes [3]. Group 3: Regulatory and Compliance - The units were issued under the listed issuer financing exemption, making the common shares and warrants immediately tradeable under Canadian securities legislation [4]. - The final tranche of the offering is expected to close around November 28, 2025, pending approval from the TSX Venture Exchange [6]. Group 4: Broker Compensation - The agents received a cash commission of 6.0% on the gross proceeds from the first tranche and non-transferable common share purchase warrants equivalent to 6.0% of the units sold [5].

SLINGERLANDS, N.Y., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG) (the “Company” or “Plug”), a global leader in comprehensive hydrogen solutions for the hydrogen economy, will hold a Special Meeting of Stockholders (the “Special Meeting”) on January 15, 2026, at 10:00 a.m. Eastern Time. The meeting will be conducted in a virtual format only. Purpose of the Special Meeting At the upcoming Special Meeting, Plug will ask stockholders to approve an amendment to the Company’s charter to increa ...

SMITHFIELD, Va., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Smithfield Foods donated 32,000 pounds of protein to the 29th Annual Mayflower Marathon Holiday Food and Fund Drive to support the Virginia Peninsula Foodbank and Foodbank of Southeastern Virginia and the Eastern Shore. “Providing access to protein is a key part of our commitment to fighting hunger in the communities where we live and work,” said Jonathan Toms, senior community development manager for Smithfield Foods. “The Mayflower Marathon is a testament ...

-- Tablet PK exposure increases proportionally with an increase in dose -- -- More favorable PK properties in tablets enable a lower dose to achieve the same exposure as the capsule formulation, with improved predictability and reduced variability -- -- Tablet steady state showing Cmax/Cmin ratio <2 -- MIAMI, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic oral ...

Transparency notification by Groupe Bruxelles Lambert S.A. In accordance with article 14, § 1 of the law of 2 May 2007 on the disclosure of major holdings, Umicore was recently notified by Groupe Bruxelles Lambert S.A. that it has crossed the legal threshold of 10% for the direct voting rights downwards on 18 November 2025. The total holding of direct voting rights and equivalent financial instruments of Groupe Bruxelles Lambert S.A. stands at 7.96% on 18 November 2025. Summary of the move by Groupe Bruxell ...

Core Points - Bank of America Corporation has crossed the legal threshold of 3% for direct voting rights and equivalent financial instruments in Umicore, reaching a total holding of 3.53% as of 18 November 2025 [2][8]. Company Overview - Umicore is a global advanced materials and recycling group, focusing on transforming precious and critical metals into functional technologies for everyday applications [6]. - The company operates with a unique circular business model that ensures continuous refinement and recycling of critical elements for reintegration into new applications [6]. Business Segments - Umicore has four main business groups: Catalysis, Recycling, Specialty Materials, and Battery Materials Solutions, which address resource scarcity and the demand for functional materials in clean technologies and mobility [7]. - The company emphasizes innovation and sustainability through tailored products and processes [7]. Financial Performance - In the first half of 2025, Umicore generated revenues of €1.8 billion (with a turnover of €8.7 billion), primarily focusing on clean mobility and recycling [10].

gategroup Holding AG (“gategroup”) is pleased to announce the successful upsizing and repricing of its Term Loan B facilities. The company increased its euro denominated facility through a fully fungible add-on of EUR 215 million and its U.S. dollar denominated facility by USD 75 million, further strengthening the liquidity position and enhancing financial flexibility to support long-term growth. The transaction was met with strong investor demand resulting in a margin reduction of 75 basis points to 350 b ...

WILMINGTON, Del., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW) (OTC: ONFOP) (the "Company" or "Onfolio"), a company that combines digital assets, DeFi yield, and cash-flowing online businesses, today announced that it has received $4.75 million in investment proceeds under its previously announced financing agreement. The Company has allocated approximately $2.35 million toward business growth initiatives, repayment of debt and working capital, and approximately $2.4 million ...

TORONTO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases and medical countermeasures, announced today an update on its ongoing research study evaluating Bucillamine as a potential treatment for nerve agent exposure. The study is being conducted in collaboration with Defence R&D Canada – Suffield Research Centre (“ ...